Steven Cohen's VERA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.21 M shares of Vera Therapeutics, Inc. (VERA) worth $48.71 M, representing 0.06% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in VERA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 1.27 M shares. Largest reduction occurred in Q2 2024, reducing 1.06 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Vera Therapeutics (VERA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vera Therapeutics (VERA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -527,660 | Reduce 30.35% | 1.21 M | $40.23 |
| Q4 2025 | +466,358 | Add 36.66% | 1.74 M | $50.64 |
| Q3 2025 | +1.27 M | New Buy | 1.27 M | $29.06 |
| Q1 2025 | -194,027 | Sold Out | 0 | $0.00 |
| Q4 2024 | +22,454 | Add 13.09% | 194,027 | $42.29 |
| Q3 2024 | +52,573 | Add 44.18% | 171,573 | $44.20 |
| Q2 2024 | -1.06 M | Reduce 89.87% | 119,000 | $36.18 |
| Q1 2024 | +190,824 | Add 19.39% | 1.18 M | $43.12 |
| Q4 2023 | +984,324 | New Buy | 984,324 | $15.38 |
| Q2 2023 | -1.04 M | Sold Out | 0 | $0.00 |
| Q1 2023 | +1.04 M | New Buy | 1.04 M | $7.76 |
| Q4 2022 | -121,000 | Sold Out | 0 | $0.00 |
| Q3 2022 | +121,000 | New Buy | 121,000 | $21.31 |
Steven Cohen's Vera Therapeutics Investment FAQs
Steven Cohen first purchased Vera Therapeutics, Inc. (VERA) in Q3 2022, acquiring 121,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Vera Therapeutics, Inc. (VERA) for 13 quarters since Q3 2022.
Steven Cohen's largest addition to Vera Therapeutics, Inc. (VERA) was in Q3 2025, adding 1,272,027 shares worth $36.97 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,210,725 shares of Vera Therapeutics, Inc. (VERA), valued at approximately $48.71 M.
As of the Q1 2026 filing, Vera Therapeutics, Inc. (VERA) represents approximately 0.06% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Vera Therapeutics, Inc. (VERA) was 1,738,385 shares, as reported at the end of Q4 2025.